Catabasis Pharmaceuticals Stock Price

-0.03 (-1.84%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Catabasis Pharmaceuticals Inc CATB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -1.84% 1.60 13:38:06
Open Price Low Price High Price Close Price Prev Close
1.62 1.595 1.655 1.63
Bid Price Ask Price Spread News
1.60 1.61 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
885 149,954 $ 1.62 $ 243,420 - 1.25 - 8.59
Last Trade Time Type Quantity Stock Price Currency
13:38:57 1 $ 1.60 USD


Draw Mode:

Catabasis Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 123.12M 76.95M 74.45M $ - $ - -2.03 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 4.47M 0.70%

more financials information »

Catabasis Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CATB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.621.821.581.69529,711-0.02-1.23%
1 Month2.29432.341.581.87729,254-0.6943-30.26%
3 Months2.262.621.582.071,145,264-0.66-29.2%
6 Months2.787.971.583.663,467,912-1.18-42.45%
1 Year6.678.591.253.033,091,294-5.07-76.01%
3 Years7.109.761.253.591,227,003-5.50-77.46%
5 Years38.4078.901.258.541,039,328-36.80-95.83%

Catabasis Pharmaceuticals Description

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company focuses on the discovery, development and commercialization of novel therapeutics.It develops products for the treatment of hereditary angioedema, or HAE, a rare, debilitating and potentially life-threatening disease. Its product candidate includes QLS-215.

Your Recent History
Catabasis ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.